UBA1 and VEXAS syndrome: Epidemiologic studies suggest that pathogenic and likely pathogenic UBA1 variants are more common than expected, with prevalence estimates near 1 in 4,000 men older than 50 years, albeit with evidence of incomplete clinical penetrance of VEXAS syndrome–associated UBA1 variants (2, 3).